LES HOPITAUX UNIV DE GENEVE has a total of 16 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2013. It filed its patents most often in EPO (European Patent Office), Australia and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are PUGET SOUND BLOOD CT, PROVIDENCE HEALTH SYSTEM and KATAYAMA CHEM IND CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | Australia | 3 | |
#3 | United States | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Peptides | |
#5 | Microorganisms | |
#6 | Object sterilising | |
#7 | Electrotherapy | |
#8 | Implantable devices |
# | Name | Total Patents |
---|---|---|
#1 | Mérat Rastine | 4 |
#2 | Zeilhofer Hanns Ulrich | 3 |
#3 | Matthey Alain | 3 |
#4 | Ralvenius William T | 3 |
#5 | Daali Youssef | 3 |
#6 | Desmeules Jules | 3 |
#7 | Besson Marie | 3 |
#8 | Vuilleumier Nicolas | 2 |
#9 | Cutler Paul | 2 |
#10 | Ferber Philippe | 2 |
Publication | Filing date | Title |
---|---|---|
EP3795184A1 | Cellular substitutes and methods of preparation thereof | |
EP3375455A1 | Agents enhancing hur/elav protein levels for use in the treatment of braf-mutated cancers | |
WO2016139586A1 | Use of n-desmethylclobazam in the treatment of chronic pain disorders and related methods | |
AU2014210770A1 | Implant for lower limb amputation | |
EP2762196A1 | Device for electrical stimulation of neural or muscular tissue |